Predictive factors for disease progression in moderate to severe COVID-19 patients

n. boubaker (Ariana, Tunisia), S. Louhaichi (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), S. Belkhir (Ariana, Tunisia), M. Ferchichi (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia)

Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Session: COVID – 19: treatments and predictive factors
Session type: E-poster
Number: 809

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
n. boubaker (Ariana, Tunisia), S. Louhaichi (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), S. Belkhir (Ariana, Tunisia), M. Ferchichi (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia). Predictive factors for disease progression in moderate to severe COVID-19 patients. 809

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Phenotypic factors as predictors of thrombotic conditionsin patients with chronic obstructive disease
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Exercise desaturation in patients with COPD – potent  marker for more severe disease progression and prognosis
Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases
Year: 2017


Development of a predictive model for chronic obstructive pulmonary disease onset with identification and ranking of risk factors
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Prevalence and impact of chronic respiratory disease in moderate to severe COVID-19 outcomes
Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Year: 2021


MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (1) 00074-2016; 10.1183/23120541.00074-2016
Year: 2017



Predictive factors of mortality in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 76s
Year: 2007

Prevalence and associated factors of osteoporosis among patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010


Is pain a risk factor for symptom severity in patients with chronic obstructive pulmonary disease?
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020


Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Comorbidities in COPD patients are not associated to higher disease severity
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011


Predictive factors of bronchiectasis acute exacerbation severity
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Clinical characteristics and related risk factors of depression in patients with early COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011



Predictive factors of endothelial function in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Prevalence and risk factors of depression in patients with COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009


Pre-COVID-19 lung function and other risk factors for severe COVID-19 in first responders
Source: ERJ Open Res, 7 (1) 00610-2020; 10.1183/23120541.00610-2020
Year: 2021



Evaluation of metabolic profile in patients with chronic obstructive pulmonary disease and correlation between the metabolic parameters and the severity of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006

Predictive modelling of COPD exacerbation rates using baseline risk factors
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020




Investigating the fatigue and related factors in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease
Year: 2017